Obesity induces a pro-inflammatory state that can contribute to endothelial dysfunction and coronary microvascular impairment [35], finally resulting in heart failure with preserved ejection fraction (HFpEF); there is increasing clinical evidence supporting the role of GLP-1 receptor agonists in patients with obesity-related HfpEF [36]. The gene discussed is GLP1R; the disease is obesity disorder.